360 related articles for article (PubMed ID: 23377640)
1. Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.
; ;
Am J Psychiatry; 2013 Feb; 170(2):207-17. PubMed ID: 23377640
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.
Uher R; Perroud N; Ng MY; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Zagar T; Czerski PM; Jerman B; Larsen ER; Schulze TG; Zobel A; Cohen-Woods S; Pirlo K; Butler AW; Muglia P; Barnes MR; Lathrop M; Farmer A; Breen G; Aitchison KJ; Craig I; Lewis CM; McGuffin P
Am J Psychiatry; 2010 May; 167(5):555-64. PubMed ID: 20360315
[TBL] [Abstract][Full Text] [Related]
3. New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation.
Fabbri C; Tansey KE; Perlis RH; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Breen G; Curtis C; Sang-Hyuk L; Newhouse S; Patel H; Guipponi M; Perroud N; Bondolfi G; O'Donovan M; Lewis G; Biernacka JM; Weinshilboum RM; Farmer A; Aitchison KJ; Craig I; McGuffin P; Uher R; Lewis CM
Pharmacogenomics J; 2018 May; 18(3):413-421. PubMed ID: 29160301
[TBL] [Abstract][Full Text] [Related]
4. A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.
Ising M; Lucae S; Binder EB; Bettecken T; Uhr M; Ripke S; Kohli MA; Hennings JM; Horstmann S; Kloiber S; Menke A; Bondy B; Rupprecht R; Domschke K; Baune BT; Arolt V; Rush AJ; Holsboer F; Müller-Myhsok B
Arch Gen Psychiatry; 2009 Sep; 66(9):966-975. PubMed ID: 19736353
[TBL] [Abstract][Full Text] [Related]
5. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
Fabbri C; Crisafulli C; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):723-735. PubMed ID: 28260126
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of antidepressant response: A polygenic approach.
García-González J; Tansey KE; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Žagar T; Czerski PM; Jerman B; Buttenschøn HN; Schulze TG; Zobel A; Farmer A; Aitchison KJ; Craig I; McGuffin P; Giupponi M; Perroud N; Bondolfi G; Evans D; O'Donovan M; Peters TJ; Wendland JR; Lewis G; Kapur S; Perlis R; Arolt V; Domschke K; ; Breen G; Curtis C; Sang-Hyuk L; Kan C; Newhouse S; Patel H; Baune BT; Uher R; Lewis CM; Fabbri C
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():128-134. PubMed ID: 28159590
[TBL] [Abstract][Full Text] [Related]
7. A genomewide association study of citalopram response in major depressive disorder.
Garriock HA; Kraft JB; Shyn SI; Peters EJ; Yokoyama JS; Jenkins GD; Reinalda MS; Slager SL; McGrath PJ; Hamilton SP
Biol Psychiatry; 2010 Jan; 67(2):133-8. PubMed ID: 19846067
[TBL] [Abstract][Full Text] [Related]
8. A genome-wide association study of a sustained pattern of antidepressant response.
Hunter AM; Leuchter AF; Power RA; Muthén B; McGrath PJ; Lewis CM; Cook IA; Garriock HA; McGuffin P; Uher R; Hamilton SP
J Psychiatr Res; 2013 Sep; 47(9):1157-65. PubMed ID: 23726668
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics in major depression: a comprehensive meta-analysis.
Niitsu T; Fabbri C; Bentini F; Serretti A
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():183-94. PubMed ID: 23733030
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
Adkins DE; Clark SL; Åberg K; Hettema JM; Bukszár J; McClay JL; Souza RP; van den Oord EJ
Transl Psychiatry; 2012 Jul; 2(7):e129. PubMed ID: 22760553
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.
Wong ML; Dong C; Flores DL; Ehrhart-Bornstein M; Bornstein S; Arcos-Burgos M; Licinio J
Am J Psychiatry; 2014 Dec; 171(12):1297-309. PubMed ID: 25220861
[TBL] [Abstract][Full Text] [Related]
12. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms.
Uher R; Perlis RH; Henigsberg N; Zobel A; Rietschel M; Mors O; Hauser J; Dernovsek MZ; Souery D; Bajs M; Maier W; Aitchison KJ; Farmer A; McGuffin P
Psychol Med; 2012 May; 42(5):967-80. PubMed ID: 21929846
[TBL] [Abstract][Full Text] [Related]
13. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.
Binder EB; Owens MJ; Liu W; Deveau TC; Rush AJ; Trivedi MH; Fava M; Bradley B; Ressler KJ; Nemeroff CB
Arch Gen Psychiatry; 2010 Apr; 67(4):369-79. PubMed ID: 20368512
[TBL] [Abstract][Full Text] [Related]
14. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
Uher R; Mors O; Rietschel M; Rajewska-Rager A; Petrovic A; Zobel A; Henigsberg N; Mendlewicz J; Aitchison KJ; Farmer A; McGuffin P
J Clin Psychiatry; 2011 Nov; 72(11):1478-84. PubMed ID: 22127194
[TBL] [Abstract][Full Text] [Related]
15. Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.
Paddock S; Laje G; Charney D; Rush AJ; Wilson AF; Sorant AJ; Lipsky R; Wisniewski SR; Manji H; McMahon FJ
Am J Psychiatry; 2007 Aug; 164(8):1181-8. PubMed ID: 17671280
[TBL] [Abstract][Full Text] [Related]
16. Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder.
Cutler JA; Rush AJ; McMahon FJ; Laje G
J Psychopharmacol; 2012 Mar; 26(3):360-7. PubMed ID: 22282879
[TBL] [Abstract][Full Text] [Related]
17. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
McMahon FJ; Buervenich S; Charney D; Lipsky R; Rush AJ; Wilson AF; Sorant AJM; Papanicolaou GJ; Laje G; Fava M; Trivedi MH; Wisniewski SR; Manji H
Am J Hum Genet; 2006 May; 78(5):804-814. PubMed ID: 16642436
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide association studies of antidepressant outcome: a brief review.
Laje G; McMahon FJ
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1553-7. PubMed ID: 21115088
[TBL] [Abstract][Full Text] [Related]
19. SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
Shiroma PR; Drews MS; Geske JR; Mrazek DA
Am J Geriatr Psychiatry; 2014 Nov; 22(11):1140-8. PubMed ID: 23973251
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project.
Perroud N; Uher R; Ng MY; Guipponi M; Hauser J; Henigsberg N; Maier W; Mors O; Gennarelli M; Rietschel M; Souery D; Dernovsek MZ; Stamp AS; Lathrop M; Farmer A; Breen G; Aitchison KJ; Lewis CM; Craig IW; McGuffin P
Pharmacogenomics J; 2012 Feb; 12(1):68-77. PubMed ID: 20877300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
